- Ownership
-
Verona Pharma plc Insider Trading
* In original currency USD
Loading Data
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Monday, June 16th, 2025 | Fisher Andrew | officer: General Counsel | 2,240,000 | M-Exempt | D | 80,000 | 2.01 USD | 160,904 USD |
| Monday, June 16th, 2025 | Fisher Andrew | officer: General Counsel | 439,999 | M-Exempt | A | 80,000 | 2.01 USD | 160,904 USD |
| Monday, June 16th, 2025 | Fisher Andrew | officer: General Counsel | 359,999 | S-Sale | D | 80,000 | 11.53 USD | 922,000 USD |
| Thursday, May 15th, 2025 | Fisher Andrew | officer: General Counsel | 2,320,000 | M-Exempt | D | 80,000 | 2.01 USD | 160,904 USD |
| Thursday, May 15th, 2025 | Fisher Andrew | officer: General Counsel | 439,999 | M-Exempt | A | 80,000 | 2.01 USD | 160,904 USD |
| Wednesday, June 11th, 2025 | Hahn Mark W | officer: Chief Financial Officer | 12,278,992 | S-Sale | D | 400,000 | 11.40 USD | 4,560,360 USD |
| Wednesday, June 11th, 2025 | ZACCARDELLI DAVID | director, officer: President and CEO | 13,190,168 | S-Sale | D | 400,000 | 11.40 USD | 4,560,520 USD |
| Tuesday, May 27th, 2025 | Hahn Mark W | officer: Chief Financial Officer | 13,046,560 | S-Sale | D | 32,432 | 9.53 USD | 308,983 USD |
| Wednesday, May 28th, 2025 | Hahn Mark W | officer: Chief Financial Officer | 12,883,856 | S-Sale | D | 162,704 | 9.30 USD | 1,513,294 USD |
| Thursday, May 29th, 2025 | Hahn Mark W | officer: Chief Financial Officer | 12,678,992 | S-Sale | D | 204,864 | 9.33 USD | 1,911,668 USD |
| Tuesday, May 27th, 2025 | ZACCARDELLI DAVID | director, officer: President and CEO | 13,956,568 | S-Sale | D | 33,600 | 9.53 USD | 320,181 USD |
| Wednesday, May 28th, 2025 | ZACCARDELLI DAVID | director, officer: President and CEO | 13,798,864 | S-Sale | D | 157,704 | 9.30 USD | 1,466,805 USD |
| Thursday, May 29th, 2025 | ZACCARDELLI DAVID | director, officer: President and CEO | 13,590,168 | S-Sale | D | 208,696 | 9.33 USD | 1,947,593 USD |
| Tuesday, May 20th, 2025 | Sinha Vikas | director | 234,440 | M-Exempt | A | 160,000 | 0.50 USD | 80,608 USD |
| Tuesday, May 20th, 2025 | Sinha Vikas | director | 74,440 | S-Sale | D | 160,000 | 9.39 USD | 1,502,928 USD |
| Tuesday, May 20th, 2025 | Sinha Vikas | director | 384 | M-Exempt | D | 160,000 | 0.50 USD | 80,608 USD |
| Tuesday, April 29th, 2025 | Sinha Vikas | director | 194,824 | M-Exempt | A | 120,384 | 1.70 USD | 204,653 USD |
| Tuesday, April 29th, 2025 | Sinha Vikas | director | 160,384 | M-Exempt | D | 39,616 | 0.50 USD | 19,959 USD |
| Tuesday, April 29th, 2025 | Sinha Vikas | director | 114,056 | M-Exempt | A | 39,616 | 0.50 USD | 19,959 USD |
| Tuesday, April 29th, 2025 | Sinha Vikas | director | 0 | M-Exempt | D | 120,384 | 1.70 USD | 204,653 USD |
| Thursday, May 15th, 2025 | Fisher Andrew | officer: General Counsel | 2,320,000 | M-Exempt | D | 80,000 | 2.11 USD | 169,040 USD |
| Thursday, May 15th, 2025 | Fisher Andrew | officer: General Counsel | 439,999 | M-Exempt | A | 80,000 | 2.11 USD | 169,040 USD |
| Thursday, May 15th, 2025 | Fisher Andrew | officer: General Counsel | 359,999 | S-Sale | D | 80,000 | 8.57 USD | 685,600 USD |
| Wednesday, May 14th, 2025 | ACKERMANN CHRISTINA | director | 200,000 | M-Exempt | D | 40,000 | 1.93 USD | 77,352 USD |
| Wednesday, May 14th, 2025 | ACKERMANN CHRISTINA | director | 81,880 | M-Exempt | A | 40,000 | 1.93 USD | 77,352 USD |
| Wednesday, May 14th, 2025 | ACKERMANN CHRISTINA | director | 41,880 | S-Sale | D | 40,000 | 8.44 USD | 337,600 USD |
| Tuesday, May 6th, 2025 | Rickard Kathleen A. | officer: Chief Medical Officer | 2,546,472 | S-Sale | D | 114,984 | 8.82 USD | 1,014,343 USD |
| Thursday, May 1st, 2025 | Rickard Kathleen A. | officer: Chief Medical Officer | 2,683,320 | M-Exempt | A | 50,000 | 0.00 USD | 0 USD |
| Thursday, May 1st, 2025 | Rickard Kathleen A. | officer: Chief Medical Officer | 2,661,456 | S-Sale | D | 21,864 | 8.95 USD | 195,687 USD |
| Thursday, May 1st, 2025 | Rickard Kathleen A. | officer: Chief Medical Officer | 2,633,320 | S-Sale | D | 27,336 | 8.95 USD | 244,663 USD |
| Thursday, May 1st, 2025 | Rickard Kathleen A. | officer: Chief Medical Officer | 250,000 | M-Exempt | D | 50,000 | 0.00 USD | 0 USD |
| Thursday, May 1st, 2025 | Hahn Mark W | officer: Chief Financial Officer | 13,557,728 | M-Exempt | A | 200,000 | 0.00 USD | 0 USD |
| Thursday, May 1st, 2025 | Hahn Mark W | officer: Chief Financial Officer | 13,478,992 | S-Sale | D | 78,736 | 8.95 USD | 704,703 USD |
| Thursday, May 1st, 2025 | Hahn Mark W | officer: Chief Financial Officer | 13,357,728 | S-Sale | D | 108,272 | 8.95 USD | 969,056 USD |
| Friday, May 2nd, 2025 | Hahn Mark W | officer: Chief Financial Officer | 13,078,992 | S-Sale | D | 400,000 | 9.09 USD | 3,637,720 USD |
| Thursday, May 1st, 2025 | Hahn Mark W | officer: Chief Financial Officer | 1,000,000 | M-Exempt | D | 200,000 | 0.00 USD | 0 USD |
| Thursday, May 1st, 2025 | EBSWORTH DAVID R | director | 1,476,003 | M-Exempt | A | 140,000 | 1.93 USD | 270,732 USD |
| Thursday, May 1st, 2025 | EBSWORTH DAVID R | director | 0 | M-Exempt | A | 140,000 | 1.93 USD | 270,732 USD |
| Thursday, May 1st, 2025 | ZACCARDELLI DAVID | director, officer: President and CEO | 14,468,904 | M-Exempt | A | 200,000 | 0.00 USD | 0 USD |
| Thursday, May 1st, 2025 | ZACCARDELLI DAVID | director, officer: President and CEO | 14,390,168 | S-Sale | D | 78,736 | 8.95 USD | 704,703 USD |
| Thursday, May 1st, 2025 | ZACCARDELLI DAVID | director, officer: President and CEO | 14,268,904 | S-Sale | D | 108,272 | 8.95 USD | 969,056 USD |
| Friday, May 2nd, 2025 | ZACCARDELLI DAVID | director, officer: President and CEO | 13,990,168 | S-Sale | D | 400,000 | 9.09 USD | 3,637,520 USD |
| Thursday, May 1st, 2025 | ZACCARDELLI DAVID | director, officer: President and CEO | 1,000,000 | M-Exempt | D | 200,000 | 0.00 USD | 0 USD |
| Tuesday, April 29th, 2025 | Fisher Andrew | officer: General Counsel | 386,065 | M-Exempt | A | 86,064 | 0.00 USD | 0 USD |
| Tuesday, April 29th, 2025 | Fisher Andrew | officer: General Counsel | 359,993 | S-Sale | D | 26,072 | 8.98 USD | 234,127 USD |
| Wednesday, March 19th, 2025 | Fisher Andrew | officer: General Counsel | 300,001 | G-Gift | A | 1 | 0.00 USD | 0 USD |
| Tuesday, April 29th, 2025 | Fisher Andrew | officer: General Counsel | 253,120 | A-Award | A | 253,120 | 0.00 USD | 0 USD |
| Tuesday, April 29th, 2025 | Fisher Andrew | officer: General Counsel | 167,056 | M-Exempt | D | 86,064 | 0.00 USD | 0 USD |
| Tuesday, April 29th, 2025 | ZACCARDELLI DAVID | director, officer: President and CEO | 14,467,536 | M-Exempt | A | 229,512 | 0.00 USD | 0 USD |
| Tuesday, April 29th, 2025 | ZACCARDELLI DAVID | director, officer: President and CEO | 14,377,176 | S-Sale | D | 90,360 | 8.98 USD | 811,433 USD |
| Wednesday, August 7th, 2024 | ZACCARDELLI DAVID | director, officer: President and CEO | 1,200,000 | A-Award | A | 1,200,000 | 0.00 USD | 0 USD |
| Tuesday, April 29th, 2025 | ZACCARDELLI DAVID | director, officer: President and CEO | 675,000 | A-Award | A | 675,000 | 0.00 USD | 0 USD |
| Tuesday, April 29th, 2025 | ZACCARDELLI DAVID | director, officer: President and CEO | 445,488 | M-Exempt | D | 229,512 | 0.00 USD | 0 USD |
| Tuesday, April 29th, 2025 | Rickard Kathleen A. | officer: Chief Medical Officer | 2,695,040 | M-Exempt | A | 86,064 | 0.00 USD | 0 USD |
| Tuesday, April 29th, 2025 | Rickard Kathleen A. | officer: Chief Medical Officer | 2,660,656 | S-Sale | D | 34,384 | 8.98 USD | 308,768 USD |
| Wednesday, August 7th, 2024 | Rickard Kathleen A. | officer: Chief Medical Officer | 300,000 | A-Award | A | 300,000 | 0.00 USD | 0 USD |
| Tuesday, April 29th, 2025 | Rickard Kathleen A. | officer: Chief Medical Officer | 253,120 | A-Award | A | 253,120 | 0.00 USD | 0 USD |
| Tuesday, April 29th, 2025 | Rickard Kathleen A. | officer: Chief Medical Officer | 167,056 | M-Exempt | D | 86,064 | 0.00 USD | 0 USD |
| Tuesday, April 29th, 2025 | Hahn Mark W | officer: Chief Financial Officer | 13,556,360 | M-Exempt | A | 229,512 | 0.00 USD | 0 USD |
| Tuesday, April 29th, 2025 | Hahn Mark W | officer: Chief Financial Officer | 13,466,000 | S-Sale | D | 90,360 | 8.98 USD | 811,433 USD |
| Wednesday, August 7th, 2024 | Hahn Mark W | officer: Chief Financial Officer | 1,200,000 | A-Award | A | 1,200,000 | 0.00 USD | 0 USD |
| Tuesday, April 29th, 2025 | Hahn Mark W | officer: Chief Financial Officer | 675,000 | A-Award | A | 675,000 | 0.00 USD | 0 USD |
| Tuesday, April 29th, 2025 | Hahn Mark W | officer: Chief Financial Officer | 445,488 | M-Exempt | D | 229,512 | 0.00 USD | 0 USD |
| Tuesday, April 29th, 2025 | Sinha Vikas | director | 195,048 | M-Exempt | D | 4,952 | 0.50 USD | 2,495 USD |
| Tuesday, April 29th, 2025 | Sinha Vikas | director | 89,488 | M-Exempt | A | 15,048 | 1.70 USD | 25,582 USD |
| Tuesday, April 29th, 2025 | Sinha Vikas | director | 80,952 | M-Exempt | D | 15,048 | 1.70 USD | 25,582 USD |
| Tuesday, April 29th, 2025 | Sinha Vikas | director | 79,392 | M-Exempt | A | 4,952 | 0.50 USD | 2,495 USD |
| Tuesday, April 29th, 2025 | Sinha Vikas | director | 74,440 | S-Sale | D | 4,952 | 8.92 USD | 44,176 USD |
| Friday, April 25th, 2025 | EBSWORTH DAVID R | director | 96,000 | A-Award | A | 96,000 | 0.00 USD | 0 USD |
| Friday, April 25th, 2025 | Ullman Anders | director | 96,000 | A-Award | A | 96,000 | 0.00 USD | 0 USD |
| Friday, April 25th, 2025 | Sinha Vikas | director | 96,000 | A-Award | A | 96,000 | 0.00 USD | 0 USD |
| Friday, April 25th, 2025 | SHAH MAHENDRA | director | 96,000 | A-Award | A | 96,000 | 0.00 USD | 0 USD |
| Friday, April 25th, 2025 | Edwards Martin | director | 96,000 | A-Award | A | 96,000 | 0.00 USD | 0 USD |
| Friday, April 25th, 2025 | Deschamps Lisa | director | 96,000 | A-Award | A | 96,000 | 0.00 USD | 0 USD |
| Friday, April 25th, 2025 | Cunningham Kenneth | director | 96,000 | A-Award | A | 96,000 | 0.00 USD | 0 USD |
| Friday, April 25th, 2025 | Austwick Michael | director | 96,000 | A-Award | A | 96,000 | 0.00 USD | 0 USD |
| Friday, April 25th, 2025 | Brady James Aloysius | director | 96,000 | A-Award | A | 96,000 | 0.00 USD | 0 USD |
| Friday, April 25th, 2025 | ACKERMANN CHRISTINA | director | 96,000 | A-Award | A | 96,000 | 0.00 USD | 0 USD |
| Wednesday, March 12th, 2025 | Rickard Kathleen A. | officer: Chief Medical Officer | 2,608,976 | S-Sale | D | 79,264 | 8.35 USD | 661,942 USD |
| Wednesday, February 26th, 2025 | EBSWORTH DAVID R | director | 1,400,003 | M-Exempt | A | 100,000 | 1.93 USD | 193,380 USD |
| Wednesday, February 26th, 2025 | EBSWORTH DAVID R | director | 1,336,003 | G-Gift | D | 64,000 | 0.00 USD | 0 USD |
| Wednesday, February 26th, 2025 | EBSWORTH DAVID R | director | 1,300,003 | M-Exempt | A | 96,000 | 2.67 USD | 256,320 USD |
| Wednesday, February 26th, 2025 | EBSWORTH DAVID R | director | 1,204,003 | M-Exempt | A | 200,000 | 0.50 USD | 100,760 USD |
| Wednesday, February 26th, 2025 | EBSWORTH DAVID R | director | 1,004,003 | M-Exempt | A | 64,000 | 0.78 USD | 49,600 USD |
| Wednesday, February 26th, 2025 | EBSWORTH DAVID R | director | 140,000 | M-Exempt | D | 100,000 | 1.93 USD | 193,380 USD |
| Wednesday, February 26th, 2025 | EBSWORTH DAVID R | director | 0 | M-Exempt | D | 64,000 | 0.78 USD | 49,600 USD |
| Wednesday, February 26th, 2025 | EBSWORTH DAVID R | director | 0 | M-Exempt | D | 200,000 | 0.50 USD | 100,760 USD |
| Wednesday, February 26th, 2025 | EBSWORTH DAVID R | director | 0 | M-Exempt | D | 96,000 | 2.67 USD | 256,320 USD |
| Saturday, February 1st, 2025 | ZACCARDELLI DAVID | director, officer: President and CEO | 14,404,752 | A-Award | A | 200,000 | 0.00 USD | 0 USD |
| Monday, February 3rd, 2025 | ZACCARDELLI DAVID | director, officer: President and CEO | 14,238,024 | F-InKind | D | 166,728 | 7.16 USD | 1,194,189 USD |
| Saturday, February 1st, 2025 | Hahn Mark W | officer: Chief Financial Officer | 13,493,736 | A-Award | A | 200,000 | 0.00 USD | 0 USD |
| Monday, February 3rd, 2025 | Hahn Mark W | officer: Chief Financial Officer | 13,326,848 | F-InKind | D | 166,888 | 7.16 USD | 1,195,335 USD |
| Saturday, February 1st, 2025 | Rickard Kathleen A. | officer: Chief Medical Officer | 2,721,480 | A-Award | A | 50,000 | 0.00 USD | 0 USD |
| Monday, February 3rd, 2025 | Rickard Kathleen A. | officer: Chief Medical Officer | 2,688,240 | F-InKind | D | 33,240 | 7.16 USD | 238,082 USD |
| Wednesday, December 4th, 2024 | ZACCARDELLI DAVID | director, officer: President and CEO | 15,007,816 | S-Sale | D | 67,608 | 5.00 USD | 338,162 USD |
| Thursday, December 5th, 2024 | ZACCARDELLI DAVID | director, officer: President and CEO | 14,367,552 | S-Sale | D | 640,264 | 5.01 USD | 3,205,226 USD |
| Friday, December 6th, 2024 | ZACCARDELLI DAVID | director, officer: President and CEO | 14,204,752 | S-Sale | D | 162,800 | 5.01 USD | 815,400 USD |
| Wednesday, December 4th, 2024 | Hahn Mark W | officer: Chief Financial Officer | 14,117,512 | S-Sale | D | 58,184 | 5.00 USD | 290,996 USD |
| Thursday, December 5th, 2024 | Hahn Mark W | officer: Chief Financial Officer | 13,477,464 | S-Sale | D | 640,048 | 5.01 USD | 3,204,144 USD |
| Friday, December 6th, 2024 | Hahn Mark W | officer: Chief Financial Officer | 13,293,736 | S-Sale | D | 183,728 | 5.01 USD | 920,312 USD |
